初次全髋关节置换术中的预授权:延迟而无经济收益
该前瞻性匹配研究纳入2020至2022年在本机构接受初次全髋关节置换术(THA)的1788例单一商业保险患者,比较需要预授权(PA)与不需要PA两组在术前一年及从手术申请日至手术日期间的索赔费用,并比较等待时间。结果显示两组费用无差异,但需要PA的患者从申请到手术的等待时间显著更长。
要点
- 需要PA与不需要PA两组在THA术前一年的平均索赔费用无差异。
- 两组从手术申请日至手术日的平均索赔费用无差异。
- 需要PA的患者从手术申请日至手术日的等待时间显著更长。
核心结论
- 在本研究中,获取PA对于接受初次THA的患者而言是一项无效的成本节约措施。
- 需要PA的THA患者在接受手术前的等待时间显著更长。
研究设计与样本
- 前瞻性研究,纳入2020至2022年在本机构接受初次THA的1788例单一商业保险投保患者,采用匹配系列设计。
- 前瞻性收集并分析PA状态、使用服务数量以及THA术前一年和从初始手术申请日至手术日期间的非手术治疗总索赔费用数据。
主要发现
- 匹配队列比较中,THA术前一年的平均索赔费用在需要PA组为308±220美元,在不需要PA组为316±264美元,标准化均数差(SMD)=0.032。
- 从初始手术申请日至THA日期间的平均索赔费用在需要PA组为295±200美元,在不需要PA组为305±249美元,SMD=0.041。
- 需要PA的患者从初始手术申请日至THA日的等待时间显著更长(43±39天 vs 39±37天,SMD=0.083)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Prior authorization (PA) has been implemented by payers to reduce unnecessary health-care utilization. However, obtaining PA has been shown to increase the administrative burden and delay access to care. To our knowledge, financial burden and cost-effectiveness of PA in total hip arthroplasty (THA) are yet to be determined. The purpose of this prospective study was to quantify the costs associated with obtaining PA in primary THA patients. METHODS: A matched series of 1,788 patients undergoing primary THA with a single, commercial insurance payer from 2020 to 2022 at our institution was included. Data on PA status, number of services utilized, and total claims cost of nonoperative treatment received in the year before THA and incurred from the initial surgery request date to date of surgery were prospectively collected and analyzed. RESULTS: When comparing matched cohorts, no difference was found to exist among mean claim costs in the year before THA ($308 ± 220 in PA required versus $316 ± 264 in the no PA cohort, standardized mean difference [SMD) = 0.032) and incurred from initial surgery request date to date of THA ($295 ± 200 in PA required versus $305 ± 249 in the no PA cohort, SMD = 0.041). However, patients who required PA experienced a significantly longer duration from the initial surgery request date to the date of THA (43 ± 39 versus 39 days ±37, SMD = 0.083). CONCLUSION: In the present study, obtaining PA was found to be an ineffective cost-saving measure in patients undergoing primary THA. Additionally, THA patients who required PA experienced significantly longer wait times before undergoing THA.
引用
- Abe EA, Lizcano JD, Tarabichi S, et al. Prior Authorization in Primary Total Hip Arthroplasty: Delays Without Financial Gains. J Arthroplasty. 2025. PMID: 40998068. doi:10.1016/j.arth.2025.09.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。